Phoreus Biotechnology, Inc. — Form D/A

Phoreus Biotechnology, Inc. of OLATHE, KS, a company, filed a Form D amendment with the SEC on 2022-05-11. The offering totals $3.0M, of which $1.9M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
Michael CoeDirectorPerry, KS
Bradley HollidayDirectorKansas City, MO
Rajeet PannuDirectorNew York, NY
Lynn RundleDirectorAbingdon, VA
Nathan SinghDirectorSaint Louis, MO
Matthew TomichDirectorSeattle, WA
Randall ToshDirectorOlathe, KS
Michael CoeExecutive OfficerPerry, KS
Randall ToshExecutive OfficerOlathe, KS
Christopher BrandtDirectorBaltimore, MD
Matthew TomichPromoterSeattle, WA
Matthew TomichRelated PersonSeattle, WA
Rajeet PannuPromoterNew York, NY
Rajeet PannuRelated PersonNew York, NY
Xiomara Sinisterra-HunterDirectorPort Saint Lucie, FL
David SchaeferDirectorClearwater Beach, FL
David SchaeferExecutive OfficerClearwater Beach, FL
David SchaeferPromoterClearwater Beach, FL
David SchaeferRelated PersonClearwater Beach, FL
Bill AshleyDirectorOverland Park, KS
Bill AshleyPromoterOverland Park, KS
Bill AshleyRelated PersonOverland Park, KS
Steve SchramDirectorGoodyear, AZ
Steve SchramPromoterGoodyear, AZ
Steve SchramRelated PersonGoodyear, AZ

Other filings by this issuer (6)

FiledFormOfferingSold
2026-03-13D$421K
2026-03-13D/A$4.4M
2020-05-26D$2.0M
2019-12-30D/A$1.1M$550K
2019-07-19D/A$1.1M$300K
2018-08-02D$1.0M$50K

More